Sat, 08 Aug 2020

dPCR and qPCR are PCR technologies which have evolved over the years from thermostable polymerases, development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. dPCR and qPCR have been extensively used in molecular diagnostics and therefore have enabled detection of various diseases. The report would be of an interest to various stakeholders operating in the dPCR and qPCR market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

dPCR and qPCR Market to 2025- Global Analysis and Forecasts by Technology (Digital PCR (dPCR) and Quantitative PCR (qPCR)); Product (Reagents & Consumables, Instruments, and Software and Services); Application (Clinical Application, Research Application, and Forensic Application) and Geography

The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 Mn in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025.

Get Sample PDF Copy at

The market for dPCR and qPCR is expected to grow as increasing incidence of genetic diseases, growth in investments & funds for gene synthesis, increasing number of start-up companies and technological developments in PCR technologies are expected to fuel the market growth during the forecast period. In addition, the rapidly developing technologies of dPCR and qPCR and increasing ddPCR technology applications are likely to have a positive impact on the growth of the market in the coming years.

Global dPCR and qPCR Market – By Technology -Digital PCR (dPCR) -Quantitative PCR (qPCR)

Global DPCR and qPCR Market – By Product -Reagents & Consumables -Instruments -Software and Services

Global DPCR and qPCR Market – By Application -Clinical Application -Pathogen Testing -Oncology Testing -Blood Screening Testing -Research Application -Forensic Application

The major players operating in the dPCR and qPCR market Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, Fluidigm Corporation. For instance, in June 2018, Qiagen launched QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents to enable the most accurate microbial community profiling from complex microbiome samples.

Buy Complete Report at

About Us – The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Information:

Phone : +1-646-491-9876

Email Id :


Sign up for Cleveland News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!